Study of Solriamfetol Use During Pregnancy
Part of Brain & nervous system, Lungs & breathing, Mental health clinical trials.
This registry study tracks the safety of Sunosi (solriamfetol) and other wakefulness medications taken during pregnancy. It aims to gather information to help doctors and pregnant women make informed treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant.
- You have narcolepsy or obstructive sleep apnea, OR you have taken Sunosi or other wakefulness medications or stimulants during this pregnancy.
- You live in a country where solriamfetol is available for daytime sleepiness related to narcolepsy or sleep apnea.
- You are willing to sign a consent form and allow your healthcare provider to share your health information with the study.
- You have not already had your baby or learned the pregnancy outcome before being contacted by the study team.
- You have not previously participated in this study for another pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how narcolepsy or idiopathic hypersomnia affects thinking and cardiovascular health, and how usual treatment medications may change those outcomes. It may help researchers understand risks and benefits of common hypersomnia therapies.
This trial studies a “rescue” set of medicines for obstructive sleep apnea when two common treatments haven’t worked well enough. If you still have frequent breathing pauses during sleep, the study may test whether these medicines can reduce them and improve safety and symptoms.
This registry follows pregnant women with insomnia who used or did not use the sleep medication QUVIVIQ. It aims to track pregnancy and baby outcomes to understand safety.
This trial tests a medication, solriamfetol, to see if it helps people with idiopathic hypersomnia stay awake during the day. It may be an option if you have trouble staying awake despite getting enough sleep at night.
This study tests a medication called Solriamfetol (Sunosi) to see if it helps people with shift work disorder stay awake and alert during their shifts. It is a Phase 3 trial, which means it is being studied in a larger group to confirm how well it works and check for side effects.
This study tests if the drug solriamfetol can help people with major depression who also feel very tired during the day. It aims to improve both mood and daytime sleepiness.
Hear when a new Narcolepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.